Project Grant R21AI196981
Award Date 4/1/26
Completion Date 3/31/28
Dollars Obligated $461K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
- Federal Grant Award Summary Baylor College of Medicine received a $160,500 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded August 8, 2025, with a completion date of July 31, 2027. The grant funds development and validation of a novel TC-24 Enzyme-Linked Immunosorbent Assay (ELISA) test to evaluate post-treatment efficacy for Chagas disease, a neglected tropical disease endemic...
- Federal Grant Award Summary Baylor College of Medicine received a $797,087 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on February 18, 2026, with a completion date of January 31, 2031. The award supports research investigating the molecular mechanisms of transovarial transmission (TOT)—the vertical transmission of pathogens from infected ticks to their offspring—using the...
- Federal Grant Award Summary Baylor College of Medicine received a $454,791 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate the gene regulation mechanisms of tick-borne relapsing fever spirochetes. The award, dated August 22, 2025, with a completion date of July 31, 2027, supports research aimed at understanding the molecular mechanisms that enable these pathogens to...
- Federal Grant Award Summary Harvard Medical School received a $570,760 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective September 1, 2025 through August 31, 2030. This five-year research initiative will generate mechanistic and structural insights into intraflagellar transport (IFT) in Leishmania species, parasitic organisms responsible for leishmaniasis and other...
- Federal Project Grant Award Summary Baylor University received a $695,801 Project Grant awarded September 17, 2025, by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct a one-year genomic investigation of invasive Anopheles stephensi mosquitoes and their coevolution with Plasmodium falciparum malaria parasites in Africa. The research addresses critical knowledge gaps regarding the genomic bases of...
- Federal Project Grant Award Summary Baylor College of Medicine received a $160,500 Project Grant award from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025, through July 31, 2027. The grant funds the development of a Rickettsia species isolate library derived from tick specimens collected in Texas and Belize. The primary deliverables include establishment of a curated bank of Rickettsia...
- Federal Project Grant Award Summary Baylor College of Medicine received a $160,500 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective April 1, 2026 through March 31, 2028. The award supports the development and validation of a novel guinea pig animal model to study relapsing fever (RF) disease caused by Borrelia species pathogens. Relapsing fever is a vector-borne infection...
- Federal Grant Award Summary Oregon Health & Science University received a $429,000 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period April 1, 2026 through March 31, 2028. This award supports novel genetic research to elucidate critical signaling pathways in Leishmania donovani, a parasitic pathogen responsible for visceral leishmaniasis, a neglected tropical disease...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Washington University a $777,360 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025, through July 31, 2030. This award funds research titled "Advancing Lymphatic Filariasis Elimination with Parasite Genomic Epidemiology," which will deliver comprehensive genomic analysis and characterization of Wuchereria bancrofti...
- Federal Project Grant Award Summary Baylor College of Medicine received a $454,288 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025 through July 31, 2027. The award funds research investigating the immune function of the RNA helicase DDX6, specifically examining how this protein regulates hematopoietic stem cell (HSC) maintenance, quiescence, and immune...